2-223777809-T-C
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_001039569.2(AP1S3):c.64A>G(p.Thr22Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00116 in 1,613,880 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_001039569.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
AP1S3 | NM_001039569.2 | c.64A>G | p.Thr22Ala | missense_variant | 2/5 | ENST00000396654.7 | |
AP1S3 | XM_011510600.4 | c.64A>G | p.Thr22Ala | missense_variant | 2/4 | ||
AP1S3 | NR_110905.2 | n.196A>G | non_coding_transcript_exon_variant | 2/6 | |||
AP1S3 | NR_110906.2 | n.196A>G | non_coding_transcript_exon_variant | 2/4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
AP1S3 | ENST00000396654.7 | c.64A>G | p.Thr22Ala | missense_variant | 2/5 | 2 | NM_001039569.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00126 AC: 192AN: 151958Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.00110 AC: 274AN: 249482Hom.: 0 AF XY: 0.00119 AC XY: 161AN XY: 135350
GnomAD4 exome AF: 0.00115 AC: 1682AN: 1461804Hom.: 1 Cov.: 31 AF XY: 0.00119 AC XY: 866AN XY: 727198
GnomAD4 genome AF: 0.00126 AC: 192AN: 152076Hom.: 1 Cov.: 33 AF XY: 0.00129 AC XY: 96AN XY: 74316
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Mar 01, 2024 | AP1S3: BP4, BS2 - |
AP1S3-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 25, 2020 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Psoriasis 15, pustular, susceptibility to Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Al Jalila Children’s Genomics Center, Al Jalila Childrens Speciality Hospital | Dec 23, 2019 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at